Vertex, Inc. (VERX) Financial Statements
Vertex, Inc. (VERX) reported trailing twelve-month revenue of $787.4M (up 10.8% year on year) and net income of $3.6M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $28.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VERXVertex, Inc.Follow VERX — free
—
Price chart with a free account
- Market cap
- 2.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.37 | 0.43 | 0.49 | 0.57 | 0.67 | 0.75 | 0.79 | |
| Gross profit | 0.21 | 0.26 | 0.30 | 0.35 | 0.43 | 0.48 | 0.50 | |
| Research & development | 0.05 | 0.04 | 0.04 | 0.06 | 0.07 | 0.08 | 0.09 | |
| Operating income | -0.10 | -0.00 | -0.01 | -0.02 | -0.00 | 0.00 | -0.01 | |
| Pre-tax income | -0.11 | -0.00 | -0.01 | -0.02 | 0.00 | 0.01 | -0.01 | |
| Income tax | -0.03 | -0.00 | 0.00 | -0.01 | 0.05 | 0.00 | -0.01 | |
| Net income | -0.08 | -0.00 | -0.01 | -0.01 | -0.05 | 0.01 | 0.00 | |
| Diluted EPS ($) | — | — | — | -0.09 | -0.34 | 0.04 | 0.01 |
USD billions · SEC XBRL
Vertex, Inc. — questions
- What is Vertex, Inc.'s revenue?
- $787.4M over the twelve months to 2026-06-30, up 10.8% year on year, from its 10-Q and 10-K filings.
- What is Vertex, Inc.'s net income?
- $3.6M over the twelve months to 2026-06-30.
- What is Vertex, Inc.'s free cash flow?
- $28.7M over the twelve months to 2026-06-30.
- What are Vertex, Inc.'s diluted earnings per share?
- $0.01 over the twelve months to 2026-06-30.
Every figure on this page comes from Vertex, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.